Publications
1. Mitochondrial Control of Hypoxia-Induced Pathological Retinal Angiogenesis
Yagi H, Boeck M, Nian S, Neilsen K, Wang C, Lee J, Zeng Y, Grumbine M, Sweet IR, Kasai T, Negishi K, Singh SA, Aikawa M, Hellström A, Smith LEH, Fu Z. Mitochondrial control of hypoxia-induced pathological retinal angiogenesis. Angiogenesis. 2024 Aug 3. doi: 10.1007/s10456-024-09940-w. Epub ahead of print. PMID: 39096357.
https://pubmed.ncbi.nlm.nih.gov/39096357/
2. Metabolic Alterations Caused by Simultaneous Loss of HK2 and KM2 Leads to the Photoreceptor Dysfunction and Degeneration
Weh E, Goswami M, Chaudhury S, Fernando R, Miller N, Hager H, Sheskey S, Sharma V, Wubben TJ, Besirli CG. Metabolic Alterations Caused by Simultaneous Loss of HK2 and PKM2 Leads to Photoreceptor Dysfunction and Degeneration. Cells. 2023 Aug 10;12(16):2043. doi: 10.3390/cells12162043. PMID: 37626853; PMCID: PMC10453858.
https://pubmed.ncbi.nlm.nih.gov/37626853/
3. A Versatile Pumpless Multi-Channel Fluidics System for Maintenance and Real-Time Functional Assessment of Tissue and Cells
Kamat V, Grumbine MK, Bao K, Mokate K, Khalil G, Cook D, Clearwater B, Hirst R, Harman J, Boeck M, Fu Z, Smith LEH, Goswami M, Wubben TJ, Walker EM, Zhu J, Soleimanpour SA, Scarlett JM, Robbings BM, Hass D, Hurley JB, Sweet IR. A versatile pumpless multi-channel fluidics system for maintenance and real-time functional assessment of tissue and cells. Cell Rep Methods. 2023 Nov 20;3(11):100642. doi: 10.1016/j.crmeth.2023.100642. Epub 2023 Nov 13. PMID: 37963464; PMCID: PMC10694526.
https://pubmed.ncbi.nlm.nih.gov/37963464/
4. Maintaining and Assessing Various Tissue and Cell Types of the Eye Using a Novel Pumpless Fluidics System
Grumbine MK, Kamat V, Bao K, Crupi T, Mokate K, Lim R, Chao JR, Robbings BM, Hass DT, Hurley JB, Sweet IR. Maintaining and Assessing Various Tissue and Cell Types of the Eye Using a Novel Pumpless Fluidics System. J Vis Exp. 2023 Jul 14;(197). doi: 10.3791/65399. PMID: 37522735.
https://pubmed.ncbi.nlm.nih.gov/37522735/
5. A Peptide Triple Agonist of GLP-1, Neuropeptide Y1, and Neuropeptide Y2 Receptors Promotes Glycemic Control and Weight Loss
Chichura KS, Elfers CT, Salameh TS, Kamat V, Chepurny OG, McGivney A, Milliken BT, Holz GG, Applebey SV, Hayes MR, Sweet IR, Roth CL, Doyle RP. A peptide triple agonist of GLP-1, neuropeptide Y1, and neuropeptide Y2 receptors promotes glycemic control and weight loss. Sci Rep. 2023 Jun 12;13(1):9554. doi: 10.1038/s41598-023-36178-1. PMID: 37308546; PMCID: PMC10261008.
https://pubmed.ncbi.nlm.nih.gov/37308546/
6. Fluidics System for Resolving Concentration-Dependent Effects of Dissolved Gases on Tissue Metabolism
Kamat V, Robbings BM, Jung SR, Kelly J, Hurley JB, Bube KP, Sweet IR. Fluidics system for resolving concentration-dependent effects of dissolved gases on tissue metabolism. Elife. 2021 Nov 4;10:e66716. doi: 10.7554/eLife.66716. Erratum in: Elife. 2022 Feb 14;11: PMID: 34734803; PMCID: PMC8660022.
pubmed.ncbi.nlm.nih.gov/34734803/
7. BaroFuse, a Novel Pressure-Driven, Adjustable-Throughput Perfusion System for Tissue Maintenance and Assessment
Rountree A, Karkamkar A, Khalil G, Folch A, Cook DL, Sweet IR. BaroFuse, a novel pressure-driven, adjustable-throughput perfusion system for tissue maintenance and assessment. Heliyon. 2016 Dec 9;2(12):e00210. doi: 10.1016/j.heliyon.2016.e00210. PMID: 27995203; PMCID: PMC5155043.
pubmed.ncbi.nlm.nih.gov/27995203/
8. Quantification of Low-Level Drug Effects Using Real-Time, in vitro Measurement of Oxygen Consumption Rate
Neal A, Rountree AM, Philips CW, Kavanagh TJ, Williams DP, Newham P, Khalil G, Cook DL, Sweet IR. Quantification of Low-Level Drug Effects Using Real-Time, in vitro Measurement of Oxygen Consumption Rate. Toxicol Sci. 2015 Dec;148(2):594-602. doi: 10.1093/toxsci/kfv208. Epub 2015 Sep 22. PMID: 26396153; PMCID: PMC4830255.
pubmed.ncbi.nlm.nih.gov/26396153/
Yagi H, Boeck M, Nian S, Neilsen K, Wang C, Lee J, Zeng Y, Grumbine M, Sweet IR, Kasai T, Negishi K, Singh SA, Aikawa M, Hellström A, Smith LEH, Fu Z. Mitochondrial control of hypoxia-induced pathological retinal angiogenesis. Angiogenesis. 2024 Aug 3. doi: 10.1007/s10456-024-09940-w. Epub ahead of print. PMID: 39096357.
https://pubmed.ncbi.nlm.nih.gov/39096357/
2. Metabolic Alterations Caused by Simultaneous Loss of HK2 and KM2 Leads to the Photoreceptor Dysfunction and Degeneration
Weh E, Goswami M, Chaudhury S, Fernando R, Miller N, Hager H, Sheskey S, Sharma V, Wubben TJ, Besirli CG. Metabolic Alterations Caused by Simultaneous Loss of HK2 and PKM2 Leads to Photoreceptor Dysfunction and Degeneration. Cells. 2023 Aug 10;12(16):2043. doi: 10.3390/cells12162043. PMID: 37626853; PMCID: PMC10453858.
https://pubmed.ncbi.nlm.nih.gov/37626853/
3. A Versatile Pumpless Multi-Channel Fluidics System for Maintenance and Real-Time Functional Assessment of Tissue and Cells
Kamat V, Grumbine MK, Bao K, Mokate K, Khalil G, Cook D, Clearwater B, Hirst R, Harman J, Boeck M, Fu Z, Smith LEH, Goswami M, Wubben TJ, Walker EM, Zhu J, Soleimanpour SA, Scarlett JM, Robbings BM, Hass D, Hurley JB, Sweet IR. A versatile pumpless multi-channel fluidics system for maintenance and real-time functional assessment of tissue and cells. Cell Rep Methods. 2023 Nov 20;3(11):100642. doi: 10.1016/j.crmeth.2023.100642. Epub 2023 Nov 13. PMID: 37963464; PMCID: PMC10694526.
https://pubmed.ncbi.nlm.nih.gov/37963464/
4. Maintaining and Assessing Various Tissue and Cell Types of the Eye Using a Novel Pumpless Fluidics System
Grumbine MK, Kamat V, Bao K, Crupi T, Mokate K, Lim R, Chao JR, Robbings BM, Hass DT, Hurley JB, Sweet IR. Maintaining and Assessing Various Tissue and Cell Types of the Eye Using a Novel Pumpless Fluidics System. J Vis Exp. 2023 Jul 14;(197). doi: 10.3791/65399. PMID: 37522735.
https://pubmed.ncbi.nlm.nih.gov/37522735/
5. A Peptide Triple Agonist of GLP-1, Neuropeptide Y1, and Neuropeptide Y2 Receptors Promotes Glycemic Control and Weight Loss
Chichura KS, Elfers CT, Salameh TS, Kamat V, Chepurny OG, McGivney A, Milliken BT, Holz GG, Applebey SV, Hayes MR, Sweet IR, Roth CL, Doyle RP. A peptide triple agonist of GLP-1, neuropeptide Y1, and neuropeptide Y2 receptors promotes glycemic control and weight loss. Sci Rep. 2023 Jun 12;13(1):9554. doi: 10.1038/s41598-023-36178-1. PMID: 37308546; PMCID: PMC10261008.
https://pubmed.ncbi.nlm.nih.gov/37308546/
6. Fluidics System for Resolving Concentration-Dependent Effects of Dissolved Gases on Tissue Metabolism
Kamat V, Robbings BM, Jung SR, Kelly J, Hurley JB, Bube KP, Sweet IR. Fluidics system for resolving concentration-dependent effects of dissolved gases on tissue metabolism. Elife. 2021 Nov 4;10:e66716. doi: 10.7554/eLife.66716. Erratum in: Elife. 2022 Feb 14;11: PMID: 34734803; PMCID: PMC8660022.
pubmed.ncbi.nlm.nih.gov/34734803/
7. BaroFuse, a Novel Pressure-Driven, Adjustable-Throughput Perfusion System for Tissue Maintenance and Assessment
Rountree A, Karkamkar A, Khalil G, Folch A, Cook DL, Sweet IR. BaroFuse, a novel pressure-driven, adjustable-throughput perfusion system for tissue maintenance and assessment. Heliyon. 2016 Dec 9;2(12):e00210. doi: 10.1016/j.heliyon.2016.e00210. PMID: 27995203; PMCID: PMC5155043.
pubmed.ncbi.nlm.nih.gov/27995203/
8. Quantification of Low-Level Drug Effects Using Real-Time, in vitro Measurement of Oxygen Consumption Rate
Neal A, Rountree AM, Philips CW, Kavanagh TJ, Williams DP, Newham P, Khalil G, Cook DL, Sweet IR. Quantification of Low-Level Drug Effects Using Real-Time, in vitro Measurement of Oxygen Consumption Rate. Toxicol Sci. 2015 Dec;148(2):594-602. doi: 10.1093/toxsci/kfv208. Epub 2015 Sep 22. PMID: 26396153; PMCID: PMC4830255.
pubmed.ncbi.nlm.nih.gov/26396153/